Soleno Therapeutics (SLNO) Non Operating Income (2016 - 2017)
Historic Non Operating Income for Soleno Therapeutics (SLNO) over the last 5 years, with Q4 2017 value amounting to -$650000.0.
- Soleno Therapeutics' Non Operating Income fell 25795.98% to -$650000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$1.3 million, marking a year-over-year decrease of 17921.49%. This contributed to the annual value of $11.8 million for FY2024, which is 39336.39% up from last year.
- Soleno Therapeutics' Non Operating Income amounted to -$650000.0 in Q4 2017, which was down 25795.98% from $139000.0 recorded in Q3 2017.
- In the past 5 years, Soleno Therapeutics' Non Operating Income ranged from a high of $4.9 million in Q2 2015 and a low of -$9.2 million during Q1 2015
- Its 5-year average for Non Operating Income is -$443874.6, with a median of -$80000.0 in 2016.
- Data for Soleno Therapeutics' Non Operating Income shows a peak YoY increase of 43142.66% (in 2015) and a maximum YoY decrease of 11521250.0% (in 2015) over the last 5 years.
- Soleno Therapeutics' Non Operating Income (Quarter) stood at -$104965.0 in 2013, then plummeted by 1691.53% to -$1.9 million in 2014, then skyrocketed by 135.21% to $662200.0 in 2015, then crashed by 37.86% to $411497.0 in 2016, then crashed by 257.96% to -$650000.0 in 2017.
- Its Non Operating Income stands at -$650000.0 for Q4 2017, versus $139000.0 for Q3 2017 and -$88000.0 for Q2 2017.